Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP577038.RAFpFBLCGKa6rcR4uyCYRWvvrgnwC1ltrlLqhm_5lu1k4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP577038.RAFpFBLCGKa6rcR4uyCYRWvvrgnwC1ltrlLqhm_5lu1k4130_assertion type Assertion NP577038.RAFpFBLCGKa6rcR4uyCYRWvvrgnwC1ltrlLqhm_5lu1k4130_head.
- NP577038.RAFpFBLCGKa6rcR4uyCYRWvvrgnwC1ltrlLqhm_5lu1k4130_assertion description "[Using these figures as cut-off points, elevated CK-19: ABL ratios were detected in peripheral-blood samples of 20 of 37 (54%) patients with metastatic breast cancer and in bone marrow samples of 14 of 23 (61%) patients with primary breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP577038.RAFpFBLCGKa6rcR4uyCYRWvvrgnwC1ltrlLqhm_5lu1k4130_provenance.
- NP577038.RAFpFBLCGKa6rcR4uyCYRWvvrgnwC1ltrlLqhm_5lu1k4130_assertion evidence source_evidence_literature NP577038.RAFpFBLCGKa6rcR4uyCYRWvvrgnwC1ltrlLqhm_5lu1k4130_provenance.
- NP577038.RAFpFBLCGKa6rcR4uyCYRWvvrgnwC1ltrlLqhm_5lu1k4130_assertion SIO_000772 10071278 NP577038.RAFpFBLCGKa6rcR4uyCYRWvvrgnwC1ltrlLqhm_5lu1k4130_provenance.
- NP577038.RAFpFBLCGKa6rcR4uyCYRWvvrgnwC1ltrlLqhm_5lu1k4130_assertion wasDerivedFrom befree-20150227 NP577038.RAFpFBLCGKa6rcR4uyCYRWvvrgnwC1ltrlLqhm_5lu1k4130_provenance.
- NP577038.RAFpFBLCGKa6rcR4uyCYRWvvrgnwC1ltrlLqhm_5lu1k4130_assertion wasGeneratedBy ECO_0000203 NP577038.RAFpFBLCGKa6rcR4uyCYRWvvrgnwC1ltrlLqhm_5lu1k4130_provenance.